JEFFREY ARNOLD: Open Payments
NPI 1477512705 · WESTWEGO, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$737 in 36 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $137 · 2025 $737
Food & beverage: $737
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $179 |
| Novo Nordisk Inc | 11 | $153 |
| PFIZER INC. | 4 | $71 |
| Lilly USA, LLC | 4 | $65 |
| Otsuka America Pharmaceutical, Inc. | 3 | $55 |
| Edwards Lifesciences Corporation | 1 | $40 |
| Merck Sharp & Dohme LLC | 2 | $30 |
| Astellas Pharma US Inc | 1 | $24 |
| Exact Sciences Corporation | 1 | $22 |
| IRONWOOD PHARMACEUTICALS, INC | 1 | $21 |
Products named: BREZTRI, Ozempic, ELIQUIS, MOUNJARO, REXULTI, Rybelsus, FARXIGA, Wegovy.
Industry payments across LA — which companies pay providers there.
